PAPER Liang G, Gao C, Zhang L, Du H
SEARCH RESULTS
18776 RESULTS
PAPER Sintini I, Singh NA, Li D, Mielke MM, Machulda MM, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Graff-Radford J, Josephs KA, Whitwell JL
Plasma glial fibrillary acidic protein in the visual and language variants of Alzheimer's disease.
Alzheimers Dement. 2024 Mar 25; PubMed: 38528318PAPER Saghafi S, Rumbell T, Gurev V, Kozloski J, Tamagnini F, Wedgwood KC, Diekman CO
Inferring Parameters of Pyramidal Neuron Excitability in Mouse Models of Alzheimer's Disease Using Biophysical Modeling and Deep Learning.
Bull Math Biol. 2024 Mar 25;86(5):46. PubMed: 38528167PAPER Wang J, Gleeson PA, Fourriere L
Spatial-Temporal Mapping Reveals the Golgi as the Major Processing Site for the Pathogenic Swedish APP Mutation: Familial APP Mutant Shifts the Major APP Processing Site.
Traffic. 2024 Mar;25(3):e12932. PubMed: 38528836PAPER Morales-Prieto N, Bevans R, O'Mahony A, Barron A, Giles Doran C, McCarthy E, Concannon RM, Goulding SR, McCarthy CM, Collins LM, Sullivan AM, O'Keeffe GW
Human α-synuclein overexpression upregulates SKOR1 in a rat model of simulated nigrostriatal ageing.
Aging Cell. 2024 Mar 26;:e14155. PubMed: 38529808PAPER Laferrière F, Sabatier L, Claverol S, De Giorgi F, Ichas F
Biases in α-synuclein immuno-quantitation: a core problem for basic and ancillary studies of Parkinson's disease and multiple system atrophy.
Transl Neurodegener. 2024 Mar 25;13(1):15. PubMed: 38528639PAPER Li W, Li JY
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration.
Transl Neurodegener. 2024 Mar 26;13(1):16. PubMed: 38528629PAPER Yu B, Wan G, Cheng S, Wen P, Yang X, Li J, Tian H, Gao Y, Zhong Q, Liu J, Li J, Zhu Y
Disruptions of Gut Microbiota are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study.
Curr Alzheimer Res. 2024 Mar 25; PubMed: 38529601PAPER Nagori K, Pradhan M, Sharma M, Ajazuddin, Badwaik HR, Nakhate KT
Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.
Curr Alzheimer Res. 2024 Mar 25; PubMed: 38529600PAPER Sun Y, Zhang L, Ye H, Leng L, Chen Y, Su Y, Ren P, Lu H, Peng G
Potential ocular indicators to distinguish posterior cortical atrophy and typical Alzheimer's disease: a cross-section study using optical coherence tomography angiography.
Alzheimers Res Ther. 2024 Mar 25;16(1):64. PubMed: 38528626PAPER Cai H, Pang Y, Ren Z, Fu X, Jia L
Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
BMC Med. 2024 Mar 25;22(1):138. PubMed: 38528511PAPER Wang R, Sun H, Cao Y, Zhang Z, Chen Y, Wang X, Liu L, Wu J, Xu H, Wu D, Mu C, Hao Z, Qin S, Ren H, Han J, Fang M, Wang G
Glucosylceramide accumulation in microglia triggers STING-dependent neuroinflammation and neurodegeneration in mice.
Sci Signal. 2024 Mar 26;17(829):eadk8249. PubMed: 38530880PAPER Ahmadi M, Javaheri D, Khajavi M, Danesh K, Hur J
A deeply supervised adaptable neural network for diagnosis and classification of Alzheimer's severity using multitask feature extraction.
PLoS One. 2024;19(3):e0297996. Epub 2024 Mar 26 PubMed: 38530836PAPER Isaev NK, Genrikhs EE, Stelmashook EV
Methylene blue and its potential in the treatment of traumatic brain injury, brain ischemia, and Alzheimer's disease.
Rev Neurosci. 2024 Mar 27; PubMed: 38530227PAPER Das V, Miller JH, Alladi CG, Annadurai N, De Sanctis JB, Hrubá L, Hajdúch M
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies.
Med Res Rev. 2024 Mar 26; PubMed: 38530106Current Filters
- Date Range : Mar 2023 to Mar 2024 x